March Biosciences, Inc. — Form D
March Biosciences, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-22. The offering totals $22.1M, of which $22.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-22
- Form: D
- Accession: 0001123292-24-000314
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $22.1M
- Amount sold: $22.1M
- Investors: 22
- Date of first sale: 2024-10-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-527549
Issuer
- Name: March Biosciences, Inc.
- CIK: 0001965802
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 7255 Helix Park, HOUSTON, TX, 77030
- Phone: 713-898-0838
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Sarah Hein | Director | HOUSTON, TX |
| Thomas Luby | Director | Houston, TX |
| Maksim Mamonkin | Director | Houston, TX |
| Peter Olagunju | Director | Houston, TX |
| Joseph Petrosino | Director | Houston, TX |
| Sarah Hein | Executive Officer | HOUSTON, TX |
| Maksim Mamonkin | Executive Officer | Houston, TX |
Other filings by this issuer (1)
More